fda warning letters glp-1 compounding september 26 2025 Novo Nordisk calls out dangers of compounded GLP-1s in new ad FDA Issues 30 Warning Letters

The causes are multiple: metabolic changes, sleep disruption from GI symptoms, and changes in energy metabolism that affect sleep architecture

FT3: Free T3 or free triiodothyronine

In some instances, individuals experienced long-lasting stomach paralysis even after stopping Ozempic

In contrast to VitC, which is slowly imported via sodium-dependent vitamin C transporter-2 (SVCT-2) and maintained at high steady-state concentrations in the brain 6 , DHA is a transient species with remarkably different transport properties despite its structural similarity to VitC

By week 24, total weight loss from baseline commonly falls in the 12-18% range, though individual results vary significantly based on starting weight, diet, exercise, and metabolic factors